Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →This landscape tracks patent activity at the intersection of layer separation and multi-material packaging recovery — filings that claim solvent-based or enzyme-mediated delamination, aluminum layer recovery, or sorting-detectability methods for multilayer structures. The search spans 276 published records filed between 2015 and the 2026 cut-off, ranked across 72 assignees. Because the underlying corpus draws on adjacent fields such as pharmaceutical glass and medical laminates, the technology composition below reflects cross-domain filing behaviour, not a packaging-only view.
Publication lags filing by roughly 18 months, so 2025 and 2026 figures in any trend line will look thinner than they eventually turn out to be. Read the concentration and composition figures as a snapshot of claim space already staked out, not a forecast of where filing is heading next.
Pick a task. Every answer cites the patents behind it.
Two views of the same 276-record corpus: how filing volume has moved year over year, and which IPC subclasses carry the claims.
Filings rose to a peak of 7 in 2018, then declined toward a 2022 midpoint of just 1 — a growth curve that is flat or declining rather than accelerating. Treat the final one to two years as understated given publication lag, but the multi-year trend before that is not an artifact of lag.
A61K (medicinal preparations) appears on 35.9% of the 276 records and C03C (glass and enamel compositions) on 31.2%, both ahead of B32B (layered products and laminates) at 11.6% — the subclass most directly tied to multilayer packaging structure. Because records can carry multiple IPC codes, these shares sum past 100% and should be read as overlap, not as a breakdown of the whole.
Shares are the percentage of the 276 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about recycling of multilayer and multi-material packaging and every answer comes back with the patent numbers behind it.
Try EurekaA laminate is described comprising at least two substrate layers of different materials bonded together by an adhesive layer comprising one or more enzymes capable of degrading polyester-polyurethanes. The laminate can be delaminated by contacting with a delamination liquid at delamination conditions.The claim structure ties delamination triggerability to the adhesive layer itself rather than to a separate treatment step, which is the detail worth checking against any adjacent filing before designing a competing laminate.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20040097927A1 | Intervertebral disc repair | 241 |
| 2 | WO2013063275A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | 120 |
| 3 | US20130101596A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | 114 |
| 4 | US20130216742A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | 92 |
| 5 | WO2013063290A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | 89 |
| 6 | US20120316633A1 | Durable Stent Drug Eluting Coating | 76 |
| 7 | US20130239874A1 | Robust, ultraviolet-protected ambient condition history indicator and method of making same | 57 |
| 8 | US20130196096A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | 53 |
| 9 | US20130213848A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | 52 |
| 10 | US20080131638A1 | Multilayer barrier containers having increased adhesion and durability | 52 |
Citation counts favour older filings simply because they have had longer to accumulate citations inside this searched corpus — treat them as a signal of influence, not of current relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Four read-outs from the concentration, trend and citation figures above.
With the five leading assignees together holding 60.9% of all 276 records and the top ten at 79.0%, new entrants are filing into territory already substantially claimed by a small group. This is not a fragmented field where a novel angle is easy to find by volume alone.
The filing trend rose to its peak in 2018 and has not returned to that level since, with the 2022 midpoint at just 1. Combined with publication lag understating the last one to two years, the honest read is a field that saw an early wave of claims rather than one still building.
The most-cited records in this corpus are delamination-resistant pharmaceutical glass container filings, cited well above the rest of the set. That reflects their age and adjacency to a heavily cited disc-repair filing rather than current commercial weight in multilayer packaging specifically.
Only 10 co-assignee pairs appear in the dataset, and the strongest three all involve the same three individuals filing together repeatedly at a co-occurrence of 21. That points to a small number of stable inventing teams rather than a broad collaborative network.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to recycling of multilayer and multi-material packaging, with the prior art for and against each one.
The ranking below covers all 72 assignees the data endpoint returns for this search — it is not a top-50 or top-100 cut, so absence from it means absence from the corpus, not a ranking cutoff.
The leading assignee holds 93 of the 276 records in scope, more than seven times the fifth-place count of 13. That gap is unusually wide and suggests a single filer treating this as core claim territory rather than an opportunistic sideline.
By tenth place, holdings fall to 8 records — a steep decline from the leader's 93. The top ten together still account for 79.0% of the 276 records, leaving comparatively little volume spread across the remaining 62 ranked assignees.
The United States receives the largest share of filings at 87, with Europe (EPO) close behind at 70 and WIPO PCT filings at 28. Australia, China and Canada each sit in single-digit-to-low-teens territory, indicating this is primarily a US/EU prosecution story rather than a China-first one.
| Assignee | Recent year | YoY |
|---|---|---|
| Corning Inc. | 0 | — |
| ORTHOPEUTICS | 0 | — |
| Emulate Inc. | 0 | — |
| SCHAUT ROBERT ANTHONY | 0 | — |
| PEANASKY JOHN STEPHEN | 0 | — |
| DEMARTINO STEVEN EDWARD | 0 | — |
| WEEKS WENDELL P | 0 | — |
| Heart Research Institute Ltd. | 0 | — |
The figures above answer where the field stands. The next questions are usually specific to a claim, a competitor, or a filing decision.
Run a candidate claim on enzyme-mediated delamination or layer-recovery methods against the 276 records here before filing, to see which of the leading assignees' claims it sits closest to.
Search this space in EurekaThe top assignee's 93-record position and the tight co-assignee clusters suggest a small inventing team worth monitoring directly for new publications as they clear the 18-month lag.
Set up monitoring in EurekaSorting-detectability and solvent-free recovery show thinner IPC density than the core medicinal and glass classes — worth a deeper pull before assuming the angle is open.
Explore white space in EurekaOne assignee leads with 93 of the 276 records in this dataset, well ahead of the fifth-place holder at 13 records. The top five assignees combined hold 60.9% of all records in scope, and the top ten hold 79.0%, so filing activity is concentrated in a small group rather than spread evenly across the 72 ranked assignees. Anyone assessing freedom to operate here should look closely at the leader's claim scope first, since it accounts for such a disproportionate share of the corpus.
Filing activity peaked in 2018 at 7 filings in that year and has not returned to that level since, with the 2022 midpoint sitting at just 1. That is a flat-to-declining trend rather than an accelerating one. The most recent one to two years will look artificially thin because publication typically lags filing by around 18 months, so treat 2025-2026 figures as provisional rather than as evidence the field has stopped.
By IPC subclass, medicinal preparations (A61K) appear on 35.9% of the 276 records and glass and enamel compositions (C03C) on 31.2%, both ahead of layered products and laminates (B32B) at 11.6%, which is the class most directly tied to multilayer packaging structure. Because a single record can carry several IPC codes, these percentages overlap and do not sum to 100%. The prominence of medicinal and glass classes reflects that this search pulls in adjacent pharmaceutical-packaging delamination work alongside packaging-specific filings.
WO2026046755A1, filed by BASF SE and published 2026-03-05, describes a laminate with substrate layers bonded by an adhesive layer containing enzymes that degrade polyester-polyurethanes, delaminated on demand by a delamination liquid under specified conditions. The claim ties triggerable delamination to the adhesive layer composition itself rather than to a separate post-processing step. Anyone designing a competing enzyme-triggered laminate should check whether their adhesive-layer chemistry and trigger mechanism fall inside this specific structure before proceeding.
Relative to the dominant medicinal-preparation and glass-composition classes, subclasses tied to sorting-detectability additives, solvent-free aluminum layer recovery, and multi-material curbside sortation show thinner representation in this corpus. That does not guarantee those areas are unclaimed elsewhere, but within this dataset's IPC composition they carry noticeably less density than the core classes. A first claim in these branches would need to specify the trigger mechanism or detection method precisely, since generic delamination-liquid claims are already well populated.
Go past this page: query the whole recycling of multilayer and multi-material packaging corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.